PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

1.080

+0.150 (16.13%)

At close: Apr 28, 2026, 4:00 PM EDT

1.130

+0.050 (4.63%)

Pre-market: Apr 29, 2026, 9:03 AM EDT

PDS Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-34.5	-37.61	-42.94	-40.85	-16.92	Upgrade
Depreciation & Amortization	0.06	0.06	0.06	0.05	0.01	Upgrade
Other Amortization	1.55	1.16	0.65	0.18	-	Upgrade
Stock-Based Compensation	4.11	6.85	7.61	5.2	4.07	Upgrade
Other Operating Activities	1.41	0.27	1.18	5.24	0.28	Upgrade
Change in Accounts Payable	1.89	-5.3	5.76	-0.09	-0.11	Upgrade
Change in Other Net Operating Assets	-2.27	-0.45	-5.96	4.57	0.18	Upgrade
Operating Cash Flow	-27.75	-35.03	-33.64	-25.71	-12.49	Upgrade
Capital Expenditures	-	-0.03	-	-	-	Upgrade
Investing Cash Flow	-	-0.03	-	-	-	Upgrade
Long-Term Debt Issued	18.16	-	-	25	-	Upgrade
Long-Term Debt Repaid	-25.73	-3.18	-0.06	-	-	Upgrade
Net Debt Issued (Repaid)	-7.56	-3.18	-0.06	25	-	Upgrade
Issuance of Common Stock	13.98	23.37	16.44	10.01	48.89	Upgrade
Repurchase of Common Stock	-	-	-	-0.27	-	Upgrade
Other Financing Activities	6.35	-	-	-0.45	-	Upgrade
Financing Cash Flow	12.77	20.19	16.38	34.29	48.89	Upgrade
Net Cash Flow	-14.98	-14.87	-17.26	8.58	36.4	Upgrade
Free Cash Flow	-27.75	-35.06	-33.64	-25.71	-12.49	Upgrade
Free Cash Flow Per Share	-0.60	-0.96	-1.09	-0.90	-0.49	Upgrade
Cash Interest Paid	2.92	3.56	3.54	0.85	-	Upgrade
Levered Free Cash Flow	-15.72	-23.34	-21.17	-16.47	-9.04	Upgrade
Unlevered Free Cash Flow	-13.93	-21.57	-19.19	-15.83	-9.04	Upgrade
Change in Working Capital	-0.38	-5.75	-0.2	4.47	0.08	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.